Objectives To investigate the association between anticholinergic drug burden (ADB),
measured with anticholinergic drug scales, and delirium and delirium severity. Design …

Drugs with anticholinergic action are widely prescribed in the elderly population due to their
potential clinical benefits. However, these benefits are limited by adverse effects which may …

Background/objectives: Available metrics for characterizing cumulative anticholinergic
exposure over time may not be well suited for use across all US data sources. In this review …

Purpose Older people are at risk of anticholinergic side effects due to changes affecting drug
elimination and higher sensitivity to drug's side effects. Anticholinergic burden scales (ABS) …

Background: Older people with cognitive impairment, including dementia and delirium, are
high users of acute care services internationally. Potentially inappropriate medication (PIM) …

The relative importance of antimuscarinic anticholinergic medications for Parkinson's
disease (PD) declined after the introduction of levodopa, such that anticholinergic …

Background Elderly adults should avoid medications with anticholinergic effects since they
may increase the risk of adverse events, including falls, delirium, and cognitive impairment …

Aim The aim of this study was to develop the Korean Anticholinergic Burden Scale through
assessment of previously developed tools, a literature review and a modified Delphi …

Objective: Cognitive impairment in schizophrenia forms the key cause of the disease's
disability, leading to serious functional, and socioeconomic implications. Dopaminergic …

Deprescribing has gained interest recently, driven by an ageing population seeing an
increasing number living with multiple long-term conditions. This, coupled with disease …